Oral Glyceryl Triacetate (GTA) in Newborns With Canavan

This study is currently recruiting participants.

Verified June 2011 by Shaare Zedek Medical Center

Sponsor:

Information provided by:

Shaare Zedek Medical Center

ClinicalTrials.gov Identifier:

NCT00724802

First received: June 18, 2008

Last updated: June 20, 2011

Last verified: June 2011

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Primary Completion Date:	August 2008 (Final data collection date for primary outcome measure)

No publications provided by Shaare Zedek Medical Center

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Segel R, Anikster Y, Zevin S, Steinberg A, Gahl WA, Fisher D, Staretz-Chacham O, Zimran A, Altarescu G. A safety trial of high dose glyceryl triacetate for Canavan disease. Mol Genet Metab. 2011 Jul;103(3):203-6. Epub 2011 Mar 15.

To Top